News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TAP Biosystems Release: New Webinar On How To Accelerate Early Process Development Presents Validation Data On Ambr15 Microbioreactors From A Major CMO


5/15/2014 9:30:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cambridge, UK: TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, today announced that it will be co-presenting a new bioprocess webinar with KBI Biopharma, a major biopharm contract development and manufacturing organisation, on Wednesday June 11th 2014 at 4pm BST / 5pm CEST / 8am PDT / 11am EDT. The live event will detail how to use the ambr15™ automated microbioreactor system to speed up early process development of biologics.

Bioprocessing experts, Dr Shahid Rameez, Process Development Scientist at KBI Biopharma and Joe Jirka, ambr Product Specialist at TAP Biosystems, will present technical data on the use of the ambr15 micro bioreactor system, as a small scale cell culture mimic. To access the free webinar, scientists can register at: http://www.tapbiosystems.com/tap/news/pages/webinars.asp

During the hour long webinar, Joe Jirka will describe the functional features of ambr15 system that allow the system to replicate the characteristics of classical bioreactors at microscale (10-15 ml). Dr Rameez will then outline KBI Biopharma’s use of the ambr15 system as a high throughput strategy for cell culture process development. He will present data which compares the system’s performance to conventional bioreactors, thus validating the scalability of the ambr15 system for use in the early process development.

Joe Jirka, TAP Biosystems’ ambr Product Specialist stated: " Shortening the timeline for cell culture process development is a key factor in accelerating biopharmaceutical development and making manufacturing of biologics more cost-efficient.”

Jirka added: “Microbioreactor mimics offer an excellent method for rapidly assessing a large number of process parameters in parallel and I am delighted to be hosting a webinar with Shahid Rameez in which we’ll present proof-of-concept data for use of ambr15 as a valid scale-down model. This will demonstrate how the ambr15 microbioreactor can be used as a high-throughput method to select high yielding, stable clones and optimal cell culture parameters, helping save months with early process development timelines and increasing production of biologics.”

For Further Information Contact:
Michaela McAdam, Marketing Communications Manager, TAP Biosystems, York Way, Royston, Hertfordshire, SG8 5WY, UK. Tel: +44 (0) 1763 227200 Fax: +44 (0) 1763-227201
Email: Michaela.mcadam@tapbiosystems.com Web: www.tapbiosystems.com Twitter: @TAPBiosystems

Editor Contact:
Dr Sue Pearson, Director, International Science Writer, PO Box 170, Hitchin, Hertfordshire, SG5 3GD, UK. Tel/Fax + 44 (0) 1462-635327 Email: sue.pearson@internationalsciencewriter.com
Web: www.internationalsciencewriter.com Twitter: @ISciencewriter

About TAP Biosystems

TAP Biosystems (now part of the Sartorius Stedim Biotech Group) is a leading global provider of automated cell culture and fermentation systems for life science research, development and production. TAP's systems are in use worldwide at pharmaceutical, biotechnology and academic laboratories, supporting bioprocess development and GMP manufacture of biologics and cell therapies, as well as discovery and stem cell research programmes.

Founded in 1987, the company has offices in the UK and USA, and an extensive network of distributors in Europe and Asia offering pre- and post-sales support. www.tapbiosystems.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES